Followers | 261 |
Posts | 51333 |
Boards Moderated | 17 |
Alias Born | 08/29/2007 |
Friday, March 29, 2024 3:07:46 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent PRLD News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:06:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 10:55:32 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/11/2024 04:15:06 AM
- Prelude Therapeutics to Participate in Upcoming Healthcare Conferences • GlobeNewswire Inc. • 06/03/2024 11:01:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/30/2024 08:29:13 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/16/2024 08:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:00:43 PM
- Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/09/2024 11:01:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:20:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:12:13 AM
- Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/07/2024 11:01:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/06/2024 08:24:35 PM
- Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting • GlobeNewswire Inc. • 04/09/2024 08:35:00 PM
- Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:07:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:07:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:01:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:59:05 PM
- Prelude Therapeutics to Participate in Barclays Global Healthcare Conference • GlobeNewswire Inc. • 02/29/2024 09:05:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 10:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:22:04 PM
- Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024 • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:26:50 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM